Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012		Mar. 31, 2011
Cash flows from operating activities:
Net income (loss)	$ 377		$ (1,084)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	378		374
Amortization of premium on investment securities, net	1,226		749
Provision for loan losses			3,930
Gain on sale of securities	(45)		(26)
Stock based compensation	2		6
Decrease in accrued interest receivable	324		435
Impairment of real estate and repossessions acquired in settlement of loans	443
(Gain) loss on sale of real estate and repossessions acquired in settlement of loans	7		(13)
Income from Bank owned life insurance	(101)		(74)
Originations of mortgage loans held for sale	(16,359)		(15,910)
Proceeds from sale of loans held for sale	15,915		19,423
Decrease (increase) in other assets	(734)		1,162
(Decrease) increase in accrued interest payable	(62)		8
Decrease in other liabilities, net	(657)		(1,459)
Net cash provided by operating activities	714		7,521
Cash flows from investing activities:
Proceeds from sales of investment securities classified as available-for-sale	13,451		4,902
Proceeds from maturities of investment securities classified as available-for-sale	12,940		10,991
Purchases of investment securities classified as available-for-sale	(36,004)		(48,545)
Purchases of FHLB stock	(823)
Purchases of premises and equipment	(375)		(454)
Proceeds from disposal of real estate and repossessions acquired in settlement of loans and real estate held for sale	348		802
Costs capitalized on real estate and repossessions acquired in settlement of loans and real estate held for sale	(9)
Net loan originations	2,330		15,521
Net cash used by investing activities	(8,142)		(16,783)
Cash flows from financing activities:
Net increase (decrease) in deposits	(25,048)		813
Net increase (decrease) in borrowings	20,039		(1,088)
Dividends paid to common shareholders			(199)
Dividends paid on preferred stock	(224)		(224)
Net cash used by financing activities	(5,233)		(698)
Decrease in cash and cash equivalents	(12,661)		(9,960)
Cash and cash equivalents at beginning of period	24,731	[1]	20,166
Cash and cash equivalents at end of period	12,070		10,206
Cash paid during the period:
Interest	2,033		2,662
Supplemental disclosures of noncash financing and investing activities:
Cash dividends declared but not paid			199
Unrealized gains (losses) on available-for-sale securities, net of deferred taxes	570		(113)
Transfer from loans to real estate and repossessions acquired in settlement of loans	2,122		3,511
Transfer from long-term to short-term borrowings	$ 7,500		$ 7,000

[1] Derived from audited consolidated financial statements.